Armetheon is Drug Discovery in United States that focus on novel anticoagulants business. Founded in 2011. They cover business area such as developer, novel anticoagulant, antibiotic, cardiovascular disease, anti-arrhythmic drug candidate, ventricular tachycardia, (VT, patient, implantable cardioverter defibrillator, physician, increase efficacy, safety, utility.
2011
( 13 years old in 2024 )
Novel Anticoagulants
-
325 Sharon Park Drive
Suite 303
Menlo Park, CA 94025
United States
Private
developernovel anticoagulantantibioticcardiovascular diseaseanti-arrhythmic drug candidateventricular tachycardia(VTpatientimplantable cardioverter defibrillatorphysicianincrease efficacysafetyutility
* We use standard office opening hours in near Armetheon's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Armetheon is Drug Discovery business from United States that founded in 2011 (13 years old in 2024), Armetheon business is focusing on Novel Anticoagulants.
Armetheon headquarter office and corporate office address is located in 325 Sharon Park Drive Suite 303 Menlo Park, CA 94025 United States.
Armetheon was founded in United States.
In 2024, Armetheon is currently focus on novel anticoagulants sector.
Above is snippet of Google Trends for "novel anticoagulants" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Armetheon, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
